These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964 [TBL] [Abstract][Full Text] [Related]
10. NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma. Xiao ZJ; Liu J; Wang SQ; Zhu Y; Gao XY; Tin VP; Qin J; Wang JW; Wong MP Elife; 2017 Jul; 6():. PubMed ID: 28737489 [TBL] [Abstract][Full Text] [Related]
11. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716 [TBL] [Abstract][Full Text] [Related]
12. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11. Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181 [TBL] [Abstract][Full Text] [Related]
13. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer. Schaefer T; Steiner R; Lengerke C Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542 [TBL] [Abstract][Full Text] [Related]
14. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231 [TBL] [Abstract][Full Text] [Related]
15. SOX2 in development and cancer biology. Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296 [TBL] [Abstract][Full Text] [Related]
16. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association. Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122 [TBL] [Abstract][Full Text] [Related]
17. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells. Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378 [TBL] [Abstract][Full Text] [Related]
18. CAMK2A supported tumor initiating cells of lung adenocarcinoma by upregulating SOX2 through EZH2 phosphorylation. Wang SQ; Liu J; Qin J; Zhu Y; Tin VP; Yam JWP; Wong MP; Xiao ZJ Cell Death Dis; 2020 Jun; 11(6):410. PubMed ID: 32483123 [TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567 [TBL] [Abstract][Full Text] [Related]
20. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation. Wang Z; Kang L; Zhang H; Huang Y; Fang L; Li M; Brown PJ; Arrowsmith CH; Li J; Wong J Oncogene; 2019 Jun; 38(26):5250-5264. PubMed ID: 30894683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]